RECURSION PHARMACEUTICALS, INC. (RXRX) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $5.00K; Additional Paid in CapitalUSD $3.21B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $27.99M; Retained Earnings (Accumulated Deficit)USD $-2.32B.
- 2026-03-31: Common Stock, Value, IssuedUSD $5.00K; Additional Paid in CapitalUSD $3.19B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $26.66M; Retained Earnings (Accumulated Deficit)USD $-2.19B.
- 2025-12-31: Common Stock, Value, IssuedUSD $5.00K; Additional Paid in CapitalUSD $3.17B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $36.72M; Retained Earnings (Accumulated Deficit)USD $-2.08B.
- 2025-09-30: Common Stock, Value, IssuedUSD $5.00K; Additional Paid in CapitalUSD $2.98B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $34.09M; Retained Earnings (Accumulated Deficit)USD $-1.97B.
RECURSION PHARMACEUTICALS, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5.00K | $3.21B | $27.99M | $-2.32B | $915.00M | 3 month · $19.50M 6 month · $41.71M |
| 2026-03-31 | $5.00K | $3.19B | $26.66M | $-2.19B | $1.02B | 3 month · $22.21M |
| 2025-12-31 | $5.00K | $3.17B | $36.72M | $-2.08B | $1.13B | 12 month · $111.22M |
| 2025-09-30 | $5.00K | $2.98B | $34.09M | $-1.97B | $1.05B | 3 month · $25.24M 9 month · $87.46M |
| 2025-06-30 | $4.00K | $2.68B | $43.62M | $-1.81B | $919.15M | 3 month · $26.16M 6 month · $62.22M |
| 2025-03-31 | $4.00K | $2.55B | $14.14M | $-1.63B | $933.95M | 3 month · $36.06M |
| 2024-12-31 | $4.00K | $2.47B | $-7.64M | $-1.43B | $1.03B | 12 month · $81.69M |
| 2024-09-30 | $3.00K | $1.78B | (m) | $-1.25B | $524.56M | 3 month · $18.25M 9 month · $50.90M |
| 2024-06-30 | $3.00K | $1.74B | (m) | $-1.16B | $584.45M | 3 month · $16.52M 6 month · $32.65M |
| 2024-03-31 | $2.00K | $1.46B | (m) | $-1.06B | $401.15M | 3 month · $16.13M |
| 2023-12-31 | $2.00K | $1.43B | $0.00 | $-967.62M | $463.44M | 12 month · $53.50M |
| 2023-09-30 | $2.00K | $1.31B | (m) | $-874.63M | $437.97M | 3 month · $16.79M 9 month · $37.42M |
| 2023-06-30 | $2.00K | $1.25B | (m) | $-781.61M | $468.96M | 3 month · $11.81M 6 month · $20.62M |
| 2023-03-31 | $2.00K | $1.14B | (m) | $-704.88M | $430.18M | 3 month · $8.81M |
| 2022-12-31 | $2.00K | $1.13B | $0.00 | $-639.56M | $485.81M | 12 month · $27.91M |
| 2022-09-30 | $2.00K | $970.10M | $0.00 | $-582.06M | $388.03M | 3 month · $8.91M 9 month · $20.21M |
| 2022-06-30 | $2.00K | $959.39M | $-197.00K | $-521.62M | $437.58M | 3 month · $5.67M 6 month · $11.31M |
| 2022-03-31 | $2.00K | $949.93M | $-309.00K | $-456.06M | $493.57M | 3 month · $5.63M |
| 2021-12-31 | $2.00K | $943.14M | $-126.00K | $-400.08M | $542.94M | 12 month · $14.84M |
| 2021-09-30 | $2.00K | $934.17M | $2.00K | $-335.15M | $599.03M | 3 month · $3.36M 9 month · $10.50M |
| 2021-06-30 | $2.00K | $930.43M | (m) | $-287.72M | $642.71M | 3 month · $5.32M 6 month · $7.14M |
| 2021-03-31 | $0.00 | $11.29M | (m) | $-244.32M | $-233.03M | 3 month · $1.82M |
| 2020-12-31 | $0.00 | $7.31M | $0.00 | $-213.60M | $-206.29M | 12 month · $4.29M |
| 2020-09-30 | (m) | (m) | (m) | (m) | $-182.07M | 3 month · $1.02M 9 month · $3.20M |
| 2020-06-30 | (m) | (m) | (m) | (m) | $-159.44M | 3 month · $892.00K 6 month · $2.18M |
| 2020-03-31 | (m) | (m) | (m) | (m) | $-141.39M | 3 month · $1.29M |
| 2019-12-31 | (m) | (m) | (m) | (m) | $-124.27M | 12 month · $1.39M |
| 2018-12-31 | (m) | (m) | (m) | (m) | $-63.85M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |